Stallion Laboratories pvt. ltd
Dhaval Patel is an experienced professional in the pharmaceutical industry, currently serving as a Senior Executive at Stallion Laboratories Pvt. Ltd since October 2023. Prior roles include Executive positions at Torrent Pharmaceuticals Ltd, responsible for QA shop floor activities from October 2021 to October 2023, and Alembic Pharmaceuticals Limited, overseeing overall Quality Management System (QMS) activities from October 2020 to September 2021. Dhaval also served as an Executive at SUN PHARMA from September 2015 to October 2020, managing site qualification activities and calibration processes. Educational qualifications include a Master’s degree in Pharmacy from Babaria Institute (2013-2015) and a Bachelor of Pharmacy from Parul Institute of Pharmacy (2009-2013).
This person is not in any teams
Stallion Laboratories pvt. ltd
Stallion Laboratories incorporated in 1988 as an integrated private sector Pharmaceutical Formulation Manufacturer, has acquired an unmatched record of managing niche product in formulations with a WHO GMP approved production facility and GLP qualified stringent quality control. The path of success lies in its belief of creativity and no negotiation with the quality of work. Stallion Laboratories has emerged as a reputed pharmaceuticals company with a unique mix of inorganic and organic growth fuelled through a strategy of focused brand management , total quality management, zero defect manufacturing and customized selling concepts managed by a team of highly proficient industry professionals. Stallion Laboratories has established a wide network of distribution in the Indian market as well as on the international Arena with strategic alliances in the major Pharma markets viz. South Latin America, Africa, South East Asia, CIS region & Francophone countries. Stallion Laboratories is armed with WHO GMP , GLP & ISO 9001-2015 Certifications. Stallion Laboratories is coming up with Unit II which is proposed to be UK-MHRA, EU GMP & PICS approved plant. With its approval, Stallion aims to enter regulated markets.